Skip to main content

Table 1 Clinical, hormonal, and metabolic data in Met-anov and Met-ov groups, and in PCOS and non-PCOS controls.

From: Serum and follicular anti-Mullerian hormone levels in women with polycystic ovary syndrome (PCOS) under metformin

Group Met-anov Met-ov PCOS controls Non-PCOS controls
  Before treatment Δ Before treatment Δ   
Age (years) 27.40 ± 3.21 0.12 ± 0.15 28.08 ± 3.45 0.08 ± 0.29 27.83 ± 3.61 28.17 ± 3.58
BMI (kg/m 2 ) 23.00 ± 1.58 -0.11 ± 0.25 22.97 ± 1.37 -0.06 ± 0.10 22.84 ± 1.64 23.09 ± 1.58
WHR 0.76 ± 0.12 0.01 ± 0.02 0.77 ± 0.10 -0.00 ± 0.06 0.76 ± 0.10 0.75 ± 0.98
Ferriman-Gallwey score 12.67 ± 2.70° -1.84 ± 0.45 12.42 ± 2.43° -0.09 ± 0.03 12.0 ± 2.98° 3.25 ± 1.91
FSH (mIU/mL) 5.85 ± 1.57 0.06 ± 0.03 5.86 ± 1.32 -0.03 ± 0.04 6.04 ± 1.39 5.50 ± 1.60
LH (mIU/mL) 11.89 ± 3.87° -0.12 ± 0.31 12.56 ± 3.45° -0.76 ± 0.25 12.56 ± 3.48° 10.43 ± 2.48
TSH (μU/mL) 2.94 ± 0.75 -0.02 ± 0.07 2.99 ± 0.72 -0.06 ± 0.05 2.81 ± 0.77 3.01 ± 0.65
PRL (ng/mL) 8.90 ± 2.13 0.08 ± 0.13 9.17 ± 1.83 1.26 ± 0.06 8.26 ± 2.13 9.20 ± 1.93
E 2 (pg/mL) 52.45 ± 16.43 0.53 ± 18.60 49.79 ± 14.98 0.26 ± 0.08 50.18 ± 11.00 52.24 ± 8.65
P (ng/mL) 1.38 ± 0.43 -0.02 ± 0.04 1.33 ± 0.44 -0.11 ± 0.09 1.40 ± 0.42 1.42 ± 0.36
17-OHP (μg/L) 2.25 ± 0.50 -0.28 ± 0.07 2.06 ± 0.46 -0.13 ± 0.07 2.20 ± 0.47 1.85 ± 0.41
T (ng/mL) 4.65 ± 1.15° -1.14 ± 0.19 4.62 ± 1.13° -0.35 ± 0.12 4.71 ± 1.02° 1.10 ± 0.29
A (ng/mL) 4.82 ± 1.91° -1.63 ± 0.08 4.40 ± 1.13° -0.20 ± 0.08 4.80 ± 1.14° 1.84 ± 0.45
DHEAS (ng/mL) 2674.10 ± 189.7° -9.8 ± 0.25 2703.43 ± 204.42° -17.55 ± 0.11 2696.66 ± 215.77° 1792.50 ± 253.84
SHBG (nmol/L) 32.41 ± 3.35 °† 0.49 ± 0.32 30.41 ± 1.88° 0.75 ± 1.06 30.50 ± 2.20° 49.45 ± 5.96
FAI (%) 14.50 ± 4.13° -4.24 ± 1.39 14.63 ± 4.06° -4.57 ± 0.07 14.78 ± 5.20° 3.73 ± 1.44
Fasting glucose (mmol/L) 4.60 ± 0.49 -0.35 ± 0.06 4.61 ± 0.47 -0.08 ± 0.08 4.52 ± 0.50 4.65 ± 0.46
Fasting insulin (μU/mL) 16.20 ± 4.82°† -0.53 ± 0.22 16.51 ± 3.57° -2.31 ± 0.11 16.30 ± 4.39° 14.36 ± 2.07
GIR (mg/10 -4 U) 5.64 ± 1.18°† 0.36 ± 0.10 5.40 ± 1.59° 1.17 ± 0.14 5.21 ± 1.41° 7.45 ± 1.24
HOMA 3.20 ± 0.61°† -0.04 ± 0.17 3.73 ± 0.61° -0.41 ± 0.11 3.17 ± 0.69° 2.90 ± 0.71
AMH (ng/mL) 5.23 ± 1.59°† -2.0 ± 1.05 5.75 ± 1.59° -7.41 ± 2.32 3.92 ± 1.62° 1.56 ± 1.02
  1. *p < 0.05 vs. before treatment assessment; †p < 0.05 vs. Met-ov group; ^p < 0.05 vs. PCOS controls; °p < 0.05 vs. non-PCOS controls.